04 Mar
Rexahn Pharmaceuticals Submits Zoraxel Phase IIb Protocol to FDA (Business Wire via Yahoo! Finance)
Posted in Sexual Dysfunction on 04.03.10 by Merlyn |
ROCKVILLE, Md.—-Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction .
Comments Off